⌘K
Loading ticker…
Solventum Corporation · Healthcare · Medical Equipment
As of 2026-06-26, Solventum Corporation (SOLV) has a 3-month relative strength percentile of 75 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 3.2%, relative volume 1.29×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 75, Market Stance is mixed at 47, A/D rating C
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
SOLV is in a stage 1 base, week 3. Currently in a 115-day base; basing ADR 2.8% (broad 2.2%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 7.2% / 6.8%.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
SOLV is held by 16 ETFs as of Mar 2026. Top owner: VTI at 0.02% weight, $307M notional. Top 3 carry $773M.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.02% | $307M |
| VOOVanguard S&P 500 ETF | 0.02% | $245M |
| VBVanguard Small Cap ETF | 0.13% | $222M |
| VBRVanguard Small Cap Value ETF | 0.23% | $141M |
| IVViShares Core S&P 500 ETF | 0.02% | $124M |
| SPYState Street SPDR S&P 500 ETF | 0.02% | $113M |
| XLVState Street Health Care Select Sector SPDR ETF | 0.18% | $70M |
| IWRiShares Russell Midcap ETF | 0.08% | $37M |
| IWDiShares Russell 1000 Value ETF | 0.03% | $22M |
| SPYMState Street SPDR Portfolio S&P 500 ETF | 0.02% | $20M |
Showing 10 of 16 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SOLV Jan avg: 4.62% median: 4.62% win: 50% σ: 10.59% n: 2 2024-04-02 → 2026-05-29 | SOLV Feb avg: 2.04% median: 2.04% win: 50% σ: 7.98% n: 2 2024-04-02 → 2026-05-29 | SOLV Mar avg: -8.32% median: -8.32% win: 0% σ: 5.19% n: 2 2024-04-02 → 2026-05-29 | SOLV Apr avg: -5.27% median: -5.92% win: 33% σ: 8.12% n: 3 2024-04-02 → 2026-05-29 | SOLV May avg: 4.36% median: 10.54% win: 67% σ: 11.34% n: 3 2024-04-02 → 2026-05-29 | SOLV Jun avg: -3.56% median: -3.56% win: 50% σ: 10.36% n: 2 2024-04-02 → 2026-05-29 (current) | SOLV Jul avg: 2.72% median: 2.72% win: 50% σ: 12.20% n: 2 2024-04-02 → 2026-05-29 | SOLV Aug avg: 5.65% median: 5.65% win: 100% σ: 4.57% n: 2 2024-04-02 → 2026-05-29 | SOLV Sep avg: 4.31% median: 4.31% win: 50% σ: 6.28% n: 2 2024-04-02 → 2026-05-29 | SOLV Oct avg: -0.66% median: -0.66% win: 50% σ: 6.74% n: 2 2024-04-02 → 2026-05-29 | SOLV Nov avg: 11.01% median: 11.01% win: 50% σ: 17.66% n: 2 2024-04-02 → 2026-05-29 | SOLV Dec avg: -7.34% median: -7.34% win: 0% σ: 0.40% n: 2 2024-04-02 → 2026-05-29 |